226 related articles for article (PubMed ID: 37254959)
21. Modeling the Impact of Biomarker-Guided Versus ASCVD Risk-Guided Drug Treatment in US Adults With Stage 1 Hypertension: The National Health and Nutrition Examination Survey, 1999 to 2004.
Foti K; Wang D; Tang O; Daya NR; Commodore-Mensah Y; Juraschek SP; Christenson RH; Selvin E; McEvoy JW
Hypertension; 2024 Jul; 81(7):1599-1608. PubMed ID: 38690651
[TBL] [Abstract][Full Text] [Related]
22. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
[TBL] [Abstract][Full Text] [Related]
23. N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Nguyen K; Fan W; Bertoni A; Budoff MJ; Defilippi C; Lombardo D; Maisel A; Szklo M; Wong ND
Am J Cardiol; 2020 Apr; 125(8):1194-1201. PubMed ID: 32106929
[TBL] [Abstract][Full Text] [Related]
24. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
Vergaro G; Gentile F; Aimo A; Januzzi JL; Richards AM; Lam CSP; de Boer RA; Meems LMG; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; Emdin M
ESC Heart Fail; 2022 Aug; 9(4):2084-2095. PubMed ID: 35510529
[TBL] [Abstract][Full Text] [Related]
25. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
Avouac J; Meune C; Chenevier-Gobeaux C; Borderie D; Lefevre G; Kahan A; Allanore Y
Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
[TBL] [Abstract][Full Text] [Related]
26. Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study).
Madan N; Lee AK; Matsushita K; Hoogeveen RC; Ballantyne CM; Selvin E; McEvoy JW
Am J Cardiol; 2019 Jul; 124(2):245-252. PubMed ID: 31088661
[TBL] [Abstract][Full Text] [Related]
27. Associations between inflammation, coagulation, cardiac strain and injury, and subclinical vascular disease with frailty in older men: a cross-sectional study.
McKechnie DGJ; Patel M; Papacosta AO; Lennon LT; Ellins EA; Halcox JPJ; Ramsay SE; Whincup PH; Wannamethee SG
BMC Geriatr; 2022 May; 22(1):405. PubMed ID: 35527242
[TBL] [Abstract][Full Text] [Related]
28. Cardiac biomarkers in pediatric CKD-a prospective follow-up study.
Lindblad YT; Vavilis G; Chromek M; Quershi AR; Löwbeer C; Bárány P
Pediatr Nephrol; 2022 Dec; 37(12):3165-3175. PubMed ID: 35294668
[TBL] [Abstract][Full Text] [Related]
29. Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT.
Berry JD; Chen H; Nambi V; Ambrosius WT; Ascher SB; Shlipak MG; Ix JH; Gupta R; Killeen A; Toto RD; Kitzman DW; Ballantyne CM; de Lemos JA
Circulation; 2023 Jan; 147(4):310-323. PubMed ID: 36533535
[TBL] [Abstract][Full Text] [Related]
30. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
31. Unstable coronary plaque characteristics are associated with high-sensitivity cardiac troponin T and N-terminal Pro-Brain Natriuretic Peptide.
Altintas S; Cardinaels EP; Versteylen MO; Joosen IA; Seifert M; Wildberger JE; Crijns HJ; Nelemans PJ; Van Dieijen-Visser MP; Mingels AM; Das M; Kietselaer BL
J Cardiovasc Comput Tomogr; 2016; 10(1):82-8. PubMed ID: 26481512
[TBL] [Abstract][Full Text] [Related]
32. Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study.
Dallmeier D; Denkinger M; Peter R; Rapp K; Jaffe AS; Koenig W; Rothenbacher D;
Clin Chem; 2015 Feb; 61(2):389-99. PubMed ID: 25501933
[TBL] [Abstract][Full Text] [Related]
33. Associations of 24-Hour Urinary Sodium and Potassium Excretion with Cardiac Biomarkers: The Maastricht Study.
Martens RJH; Henry RMA; Bekers O; Dagnelie PC; van Dongen MCJM; Eussen SJPM; van Greevenbroek M; Kroon AA; Stehouwer CDA; Wesselius A; Meex SJR; Kooman JP
J Nutr; 2020 Jun; 150(6):1413-1424. PubMed ID: 32386231
[TBL] [Abstract][Full Text] [Related]
34. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT.
Ascher SB; Scherzer R; de Lemos JA; Estrella MM; Jotwani VK; Garimella PS; Bullen AL; Ambrosius WT; Ballantyne CM; Nambi V; Killeen AA; Ix JH; Shlipak MG; Berry JD
J Am Heart Assoc; 2022 Mar; 11(6):e023314. PubMed ID: 35243872
[TBL] [Abstract][Full Text] [Related]
35. Intrapartum trends of NT-proBNP and hs-cTnT in patients with severe features of preeclampsia.
Fixler JS; Byrne JJ; Mcintire DD; Nelson DB; Gary Cunningham F
Pregnancy Hypertens; 2024 Mar; 35():1-5. PubMed ID: 38029452
[TBL] [Abstract][Full Text] [Related]
36. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
[TBL] [Abstract][Full Text] [Related]
37. Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: The North South East West Trial.
Gaggin HK; Dang PV; Do LD; deFilippi CR; Christenson RH; Lewandrowski EL; Lewandrowski KB; Truong BQ; Pham VQ; Vu VH; Vu TV; Nguyen TB; Belcher AM; Femia A; Kelley C; Januzzi JL
Clin Chem; 2014 May; 60(5):758-64. PubMed ID: 24568795
[TBL] [Abstract][Full Text] [Related]
38. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
[TBL] [Abstract][Full Text] [Related]
39. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
[TBL] [Abstract][Full Text] [Related]
40. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.
Kopec M; Duma A; Helwani MA; Brown J; Brown F; Gage BF; Gibson DW; Miller JP; Novak E; Jaffe AS; Apple FS; Scott MG; Nagele P
Anesth Analg; 2017 Feb; 124(2):398-405. PubMed ID: 28002165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
